Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.1.02016
European Journal of Endocrinology, Vol 153, Issue 5, 687-691
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by González-Clemente, J M
Right arrow Articles by Vendrell, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by González-Clemente, J M
Right arrow Articles by Vendrell, J
CLINICAL STUDY

The tumour necrosis factor (TNF)-{alpha} system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus

J M González-Clemente, G Giménez-Pérez, C Richart1, M Broch1, A Caixàs, A Megia1, O Giménez-Palop, I Simón1, D Mauricio and J Vendrell1

Department of Diabetes, Endocrinology and Nutrition, Hospital de Sabadell, Sabadell, Spain 2 Diabetes and Research Unit, Hospital Universitari de Tarragona Joan XXIII, Universitat Rovira i Virgili, Spain

(Correspondence should be addressed to J-M González-Clemente, Department of Diabetes, Endocrinology and Nutrition, Hospital de Sabadell, Parc Taulí s/n, 08208 Sabadell, Spain; Email: jmgonzalez{at}cspt.es)

Objective: Pulse pressure (PP) and inflammation are important predictors of cardiovascular disease (CVD), even in the normotensive. The age-related increase in PP can be diagnosed up to 20 years earlier in subjects with type 1 diabetes mellitus (T1DM) than in the general population. Some evidence suggests that PP can stimulate inflammation. Our aim was to study the relationship between PP and plasma inflammatory proteins in normotensive subjects with T1DM.

Design: This was a cross-sectional study of a group of normotensive (<140/80 mmHg) subjects diagnosed with T1DM 14 years before. None of them had clinically proven CVD or inflammatory conditions or were on antiplatelet, antihypertensive, anti-inflammatory or lipid-lowering treatment.

Methods: The following information was recorded: sex, age, body-mass index (BMI), waist-to-hip ratio (WHR), systolic blood pressure (SBP), diastolic blood pressure (DBP), PP, mean blood pressure (MBP), smoking, alcohol intake, insulin dose, lipid profile, HbA1c, microvascular complications, and plasma concentrations of soluble receptor types 1 and 2 of tumour necrosis factor (TNF)-{alpha} (sTNFR1 and sTNFR2, respectively), interleukin-6, C-reactive protein, adiponectin and leptin.

Results: A total of 112 subjects were evaluated (aged 27.4±6.6 years, 52.7% women, BMI: 20.4±2.7 kg/m2, WHR: 0.82±0.09, SBP: 112±12 mmHg, DBP: 68±9 mmHg, PP: 45±9 mmHg, MBP: 82±9 mmHg, HbA1c: 8.2% (7.3–9.0%), 41.1% microvascular complications). After adjusting for potential confounders, only inflammatory markers of the TNF-{alpha} system correlated significantly with PP (Pearson correlation coefficient between sTNFR1 and PP: r = 0.215, P = 0.030; and between PP and sTNFR2: r = 0.238, P = 0.020).

Conclusion: In normotensive subjects with T1DM after 14 years of diagnosis, the activation of the TNF-{alpha} system is positively associated with PP levels. This finding might suggest a pathogenic role of the TNF-{alpha} system in the development of cardiovascular disease in T1DM.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.